New device aims to ease tennis elbow without drugs
NCT ID NCT07495254
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a device called Super Inductive System (SIS), combined with exercise and health education, can reduce pain and improve function in people with tennis elbow. About 224 adults with confirmed tennis elbow will receive either real SIS or a placebo version, plus standard exercise and education. Researchers will measure pain, grip strength, and quality of life over 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Super Inductive System (SIS) device
What this could lead to
If it works, this could provide a new, non-invasive treatment option for tennis elbow that reduces pain and speeds recovery.
What could go wrong
This trial hasn't started yet and is relatively small. The control group also gets exercise and education, so any added benefit from SIS may be small or absent.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LATERAL ELBOW TENDINOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anna Escribà Salvans
Mataró, Barcelona, 08303, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••